Consensus MaaT Pharma

Equities

Market Closed - Euronext Paris Other stock markets 11:29:57 2024-07-12 am EDT			5-day change	1st Jan Change
7.54 ^EUR	0.00%		-7.37%	+8.02%

Jul. 03	MaaT Pharma: first positive review by an expert committee	CF
Jul. 02	MaaT Pharma Announces First DSMB Positive Review of Ongoing Phase 2 Clinical Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT	CI

96.AVXHis2f-2pIN3QPaDic8zbhuXSUR6R4GsGUR6I1Wco.MgO04Knl1h8aVgd4BxXYuhu48kz9KtU3S4zLM81SD6JSYqP-vN3CBy0CGw~e3b2a6fe7d8e2e17b7809ac0ca1b5a54

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

7.54 EUR

Average target price

14.95 EUR

Spread / Average Target

+98.28%

High Price Target

16 EUR

Spread / Highest target

+112.20%

Low Price Target

13.8 EUR

Spread / Lowest Target

+83.02%

Trading Rating

Investor Rating

ESG Refinitiv